Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta-analysis

Yee Shen Loo1, Tse Yee Wong1, Sajesh K Veettil2

  • 1School of Pharmacy, International University Medical, Kuala Lumpur, Malaysia.

Oral Diseases
|August 8, 2020
PubMed
Abstract

Insights

Clotrimazole best prevents oral candidiasis in cancer patients, while fluconazole offers the best safety profile. Further research is needed to confirm clotrimazole

Area of Science:

  • Oncology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cancer patients undergoing treatment are at high risk for opportunistic infections like oral candidiasis.
  • Antifungal prophylaxis is crucial for managing and preventing oral candidiasis in this vulnerable population.
  • Comparative data on the efficacy and safety of various antifungal agents is essential for clinical decision-making.

Purpose of the Study:

  • To systematically review and network meta-analyze the comparative efficacy and safety of antifungal agents for preventing oral candidiasis in cancer patients.
  • To rank antifungal agents based on their effectiveness and safety profiles using surface under the cumulative ranking (SUCRA) scores.

Main Methods:

  • Systematic review and network meta-analysis of randomized controlled trials (RCTs).
  • Inclusion of 20 RCTs with 3,215 participants comparing 11 antifungal interventions against placebo or other antifungals.
  • Evaluation of relative rankings using SUCRA probability scores.

Main Results:

  • Clotrimazole demonstrated the highest efficacy in preventing oral candidiasis compared to placebo (RR, 0.21; SUCRA = 0.89).
  • Fluconazole was ranked highest for safety among antifungal agents (SUCRA = 0.80).
  • Amphotericin B showed the highest risk of adverse events (RR, 3.52) and was ranked low for safety (SUCRA = 0.18), as was clotrimazole (SUCRA = 0.36).

Conclusions:

  • Clotrimazole is the most effective agent for preventing oral candidiasis in cancer patients.
  • Fluconazole possesses the most favorable risk-benefit profile.
  • Despite its efficacy, clotrimazole cannot be definitively recommended due to a lack of direct comparative studies with other antifungals.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
492
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
422
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.1K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
697
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
570
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
823